What Is MOTS-c? The Mitochondrial Peptide for Metabolic Health
MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA and studied for its roles in metabolic regulation, exercise physiology, and age-related decline. Here is what the science shows.
What is MOTS-c?
MOTS-c (Mitochondrial ORF of the 12S rRNA Type-C) is a 16-amino-acid peptide with the sequence MRWQEMGYIFYPRKLR, encoded within the 12S ribosomal RNA gene of the human mitochondrial genome. Identified and characterised in 2015 by Lee et al. at the University of Southern California, MOTS-c belongs to a recently discovered class of molecules called mitochondria-derived peptides (MDPs) — short peptides encoded not by nuclear DNA but by the mitochondrial genome itself.
This origin distinguishes MOTS-c from virtually all other known signalling peptides. The mitochondrial genome encodes only 37 genes (13 proteins, 22 tRNAs, and 2 rRNAs) and is not typically thought of as a source of novel signalling peptides. The discovery of MOTS-c fundamentally expanded this understanding and opened a new field of mitochondrial-derived signalling research.
⚠ For in-vitro laboratory and preclinical research use only. Not for human consumption. All research must comply with applicable institutional and regulatory requirements.
Unique Mechanism: Mitochondria-to-Nucleus Signalling
One of the most striking properties of MOTS-c is its retrograde communication function — it moves from mitochondria to the nucleus in response to metabolic stress.
Under conditions of:
- •Glucose restriction
- •Oxidative stress
- •Exercise-induced metabolic demand
- •Mitochondrial dysfunction
MOTS-c is translocated into the cell nucleus, where it directly interacts with the antioxidant response element (ARE) and activates the Nrf2 transcription pathway. Nrf2 is a master regulator of cellular stress-response genes, governing antioxidant defence, inflammation resolution, and metabolic adaptation.
This makes MOTS-c a direct mediator of mitochondrial-to-nuclear communication — the mitochondria sensing metabolic stress and sending a peptide signal to the nucleus to adjust gene expression accordingly.
MOTS-c, AMPK, and Metabolic Regulation
A central downstream effect of MOTS-c studied in preclinical models is AMPK (AMP-activated protein kinase) activation. AMPK is the cellular master energy sensor:
- •Activated when: AMP/ATP ratio is high (low energy state)
- •Effect: Switches on catabolic pathways (fat oxidation, glucose uptake) and switches off anabolic pathways (fat synthesis, gluconeogenesis)
MOTS-c-induced AMPK activation in skeletal muscle and liver produces measurable downstream effects in preclinical models:
- •Increased glucose transporter (GLUT4) translocation to cell membranes
- •Enhanced fatty acid oxidation
- •Improved mitochondrial biogenesis
- •Reduced ectopic lipid accumulation
These effects have positioned MOTS-c as a compound of research interest in metabolic disease models, particularly in contexts where AMPK signalling is dysregulated.
MOTS-c and Ageing Research
Declining Levels with Age
Multiple studies have measured circulating MOTS-c in human cohorts and consistently found an age-dependent decline:
- •Significantly lower plasma MOTS-c in older vs younger adults
- •Decline begins measurably from middle age
- •Correlates with concurrent metabolic deterioration parameters
In rodent studies, tissue MOTS-c concentrations in skeletal muscle, liver, and plasma all decrease progressively with age — suggesting systemic rather than localised decline.
Restoring Physical Performance in Aged Mice
The 2021 Nature Communications study by Kim et al. provided compelling evidence for MOTS-c as an exercise-mimetic and longevity-relevant compound:
- •MOTS-c expression increases in skeletal muscle and plasma during exercise
- •Exogenous MOTS-c administration to aged (middle-aged and old) mice:
- Improved grip strength to near-young-adult levels
- Enhanced treadmill endurance
- Restored skeletal muscle metabolic parameters
- •The effect was observed across three age groups: young, middle-aged, and old mice
2025 Research: Pancreatic Islet Senescence
A significant 2025 publication in Experimental & Molecular Medicine (Nature Publishing Group) expanded MOTS-c research into pancreatic beta cell biology:
Key findings:
- •Aged mouse pancreatic islets treated with MOTS-c showed reduced cellular senescence markers
- •MOTS-c modulated nuclear gene expression and metabolites involved in beta cell ageing
- •In human clinical data from the study: T2D patients had significantly lower circulating MOTS-c than healthy age-matched controls
- •The researchers proposed a link between MOTS-c decline and pancreatic islet dysfunction in age-related diabetes
This builds on earlier human cross-sectional data showing the T2D-MOTS-c association and moves toward mechanistic explanations.
MOTS-c and the Alzheimer's Disease Research Connection
The Alzheimer's Drug Discovery Foundation has identified MOTS-c as a cognitive vitality compound of research interest, citing:
- •MOTS-c's role in mitochondrial biogenesis (relevant given mitochondrial dysfunction in neurodegeneration)
- •AMPK activation's known neuroprotective effects
- •Age-dependent decline in MOTS-c coinciding with the typical window for neurodegeneration onset
Human clinical trials in neurological contexts have not yet been published, but MOTS-c's mechanistic profile has attracted attention from ageing and neurodegeneration researchers.
Research Summary
| Parameter | Finding |
|---|---|
| Source | Mitochondrial DNA (12S rRNA gene) |
| Size | 16 amino acids |
| Endogenous levels | Decline with age; lower in T2D |
| Induced by | Exercise, metabolic stress |
| Primary mechanism | AMPK activation, Nrf2/ARE pathway |
| Preclinical effects | Improved glucose metabolism, physical performance, beta cell senescence reversal |
| Human data | Plasma levels characterised; mechanistic studies in progress |
Disclaimer: All information is for educational purposes related to in-vitro and preclinical laboratory research. MOTS-c is a research compound not approved for human therapeutic use.
Frequently Asked Questions
MOTS-c (Mitochondrial ORF of the 12S rRNA Type-C) is a 16-amino-acid peptide encoded within the 12S ribosomal RNA gene of the mitochondrial genome. It was first identified and characterised in 2015 by Changhan David Lee and colleagues at the USC Leonard Davis School of Gerontology. Unlike nuclear-encoded peptides, MOTS-c is one of only a handful of peptides known to be encoded by mitochondrial DNA, making it a unique class of signalling molecule termed a mitochondria-derived peptide (MDP). It has been detected in human plasma, skeletal muscle, and multiple organ tissues.
Under conditions of metabolic stress — including glucose restriction, oxidative stress, or high-intensity exercise — MOTS-c is translocated from mitochondria to the cell nucleus. Once in the nucleus, MOTS-c interacts with the antioxidant response element (ARE) and activates transcription of stress-response genes, particularly through the Nrf2 pathway. This mitochondria-to-nucleus signalling role positions MOTS-c as a retrograde communication molecule — a way for mitochondria to directly influence nuclear gene expression in response to metabolic conditions.
Circulating MOTS-c levels in human plasma decline measurably with age. In multiple human cohort studies, older adults show significantly lower plasma MOTS-c compared to younger controls. In rodent models, tissue MOTS-c concentrations also decrease in an age-dependent manner across skeletal muscle, liver, and plasma. This decline correlates with age-associated metabolic deterioration, leading researchers to hypothesise that falling MOTS-c may be a contributing factor in, rather than merely a marker of, age-related metabolic dysfunction.
A 2025 study published in Experimental & Molecular Medicine (Nature Publishing Group) investigated MOTS-c in the context of pancreatic beta cell senescence. The researchers found that treating aged mouse pancreatic islets with MOTS-c reduced cellular senescence markers by modulating nuclear gene expression and metabolites involved in beta cell ageing. In human data from the same study, circulating MOTS-c levels were found to be significantly lower in type 2 diabetes patients compared with healthy controls, supporting a potential role in glucose homeostasis. This adds to a growing body of evidence linking MOTS-c to metabolic disease pathways.
A landmark 2021 study published in Nature Communications (Kim et al.) established that MOTS-c is an exercise-induced mitochondrial peptide. The researchers demonstrated that physical exercise increases MOTS-c expression in skeletal muscle and circulating plasma levels in both rodents and humans. When exogenous MOTS-c was administered to aged mice, it improved physical performance including grip strength and treadmill endurance to levels approaching those of younger animals. This exercise-mimetic quality has positioned MOTS-c as a compound of research interest in exercise physiology, sarcopenia, and age-related physical decline.
AMPK (AMP-activated protein kinase) is a master cellular energy sensor and regulator, activated when cellular energy (ATP) levels are low relative to AMP. AMPK activation triggers catabolic pathways (fatty acid oxidation, glucose uptake) and inhibits anabolic pathways that consume ATP. MOTS-c has been shown to activate AMPK in metabolically active tissues including skeletal muscle and liver. AMPK activation mediates many of the metabolic effects studied in MOTS-c research — increased glucose uptake, fatty acid oxidation, mitochondrial biogenesis, and improved insulin sensitivity in preclinical models.
References
- 1.Lee C, Zeng J, Drew BG, et al. “The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.” Cell Metabolism (2015). https://pubmed.ncbi.nlm.nih.gov/25738459/
- 2.Kim SJ, Xiao J, Wan J, Cohen P, Yen K. “Mitochondrially derived peptides as novel regulators of metabolism.” Journal of Physiology (2017). https://pubmed.ncbi.nlm.nih.gov/27529197/
- 3.Kim KH, Son JM, Benayoun BA, Lee C. “The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress.” Cell Metabolism (2018). https://pubmed.ncbi.nlm.nih.gov/29576535/
- 4.Reynolds JC, Lai RW, Woodhead JST, et al. “MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.” Nature Communications (2021). https://pubmed.ncbi.nlm.nih.gov/33510148/
- 5.Ming W, Lu G, Xin S, et al. “Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes.” Experimental & Molecular Medicine (2025). https://www.nature.com/articles/s12276-025-01521-1
Related Articles
How to Reconstitute Peptides: A Step-by-Step Guide
Learn the correct technique for reconstituting lyophilised research peptides using bacteriostatic water for accurate, contamination-free preparations.
Research GuidesPeptide Storage Guide: How to Maximise Stability
Proper storage is critical to maintaining peptide integrity. Learn the correct temperature requirements and handling practices for lyophilised and reconstituted peptides.
Shop MOTS-c — Research Grade
GMP compliant · Independently tested · Next-day dispatch from Melbourne